Kymera Therapeutics, Inc. 4 Filing
Ticker: KYMR · Form: 4 · Filed: Apr 16, 2026 · CIK: 0001815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | 4 |
| Filed Date | Apr 16, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 4 filing submitted by Kymera Therapeutics, Inc. (ticker: KYMR) to the SEC on Apr 16, 2026.
Where can I view the full 4 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 16, 2026 regarding Kymera Therapeutics, Inc. (KYMR). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.